Effect of Midtreatment PET/CT-Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Locally Advanced Non–Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Effect of Midtreatment PET/CT-Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Locally Advanced Non–Small-Cell Lung Cancer

Published:2017-10-01 Issue:10 Volume:3 Page:1358
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Kong Feng-Ming¹,Ten Haken Randall K.²,Schipper Matthew³,Frey Kirk A.⁴,Hayman James²,Gross Milton⁵,Ramnath Nithya⁶,Hassan Khaled A.⁷,Matuszak Martha²,Ritter Timothy⁸,Bi Nan²,Wang Weili¹,Orringer Mark⁹,Cease Kemp B.⁶,Lawrence Theodore S.²,Kalemkerian Gregory P.⁷

Affiliation:

1. Department of Radiation Oncology, University of Michigan, Ann Arbor2IU Simon Cancer Center, Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, Indiana

2. Department of Radiation Oncology, University of Michigan, Ann Arbor

3. Department of Radiation Oncology, University of Michigan, Ann Arbor3Department of Biostatistics, University of Michigan, Ann Arbor

4. Division of Nuclear Medicine and Molecular Imaging, University of Michigan, Ann Arbor

5. Division of Nuclear Medicine and Molecular Imaging, University of Michigan, Ann Arbor5VA Ann Arbor Healthcare System, Ann Arbor, Michigan

6. VA Ann Arbor Healthcare System, Ann Arbor, Michigan6Department of Internal Medicine, University of Michigan, Ann Arbor

7. Department of Internal Medicine, University of Michigan, Ann Arbor

8. Department of Radiation Oncology, University of Michigan, Ann Arbor5VA Ann Arbor Healthcare System, Ann Arbor, Michigan

9. Section of Thoracic Surgery, Department of Surgery, University of Michigan, Ann Arbor

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Cited by 180 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Daily CBCT-based dose calculations for enhancing the safety of dose-escalation in lung cancer radiotherapy;Radiotherapy and Oncology;2024-11

2. Impact of mediastinal tumor burden and lymphatic spread in locally advanced non-small-cell lung cancer: A secondary analysis of the multicenter randomized PET-Plan trial;Radiotherapy and Oncology;2024-11

3. Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [18F]FDG-PET tumour residual uptake at 42 Gy (RTEP7–IFCT-1402): a multicentre, randomised, controlled phase 2 trial;The Lancet Oncology;2024-09

4. Treatment Response Biomarkers: Working Toward Personalized Radiotherapy for Lung Cancer;Journal of Thoracic Oncology;2024-08

5. Adapt or Perish: Adaptive RT for NSCLC;International Journal of Radiation Oncology*Biology*Physics;2024-07